Methylmalonic Acid Induces Oxaliplatin Resistance Through Promoting DNA Damage Repair via the ATM/ATR Pathway in Gastric Cancer
The FASEB Journal · 2026
DOI: 10.1096/fj.202600528r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Kai Weng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Can…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Ataxia Telangiectasia Mutated Proteins, Drug Resistance, Neoplasm, Oxaliplatin. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Surgical intervention and chemotherapy have enhanced the survival rates of patients with advanced gastric cancer. However, the development of chemotherapy resistance remains a major obstacle to effective treatment, leading to poor prognosis in these patients. Increasing evidence suggests that metabolic alterations play crucial roles in mediating chemoresistance. Here we investigate the effects of methylmalonic acid (MMA), a mitochondrial‐derived metabolite, on GC progression and oxaliplatin resistance. Analysis of clinical samples revealed that elevated serum MMA levels correlated with chemoresistance and advanced tumor stage in GC patients. Functional assays identified that MMA promoted GC cell proliferation, migration, and resistance to oxaliplatin by attenuating DNA damage. Mechanistically, MMA suppressed oxaliplatin‐induced γH2AX expression while upregulating ATAD5 and activating the ATM/ATR‐mediated homologous recombination (HR) repair pathway. In vivo studies further confirmed that MMA impaired the antitumor efficacy of oxaliplatin, while silencing PCCA, a key enzyme in MMA synthesis, or supplementing vitamin B12, a regulator of MMA metabolism, reversed MMA‐induced chemoresistance. These findings highlight MMA as a potential indicator for oxaliplatin resistance and a therapeutic target in GC. Therefore, targeting MMA through vitamin B12 supplementation could serve as a promising therapeutic strategy to overcome chemoresistance in GC patients with elevated MMA levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital & Institute, Beijing, China.
- Department of Gastrointestinal Surgery, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot, China.
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital & Institute, Beijing, China.
ORCID-Profile: Kai Weng, Jiangbo Chen, Fei Tan, Lin Song, Tongkun Song, Xinying Yang, Kai Xu, Hong Yang, Xiangqian Su
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program of CPSF
- Science Foundation of Peking University Cancer Hospital
- Natural Science Foundation of Inner Mongolia Autonomous Region of China
- Clinical Research Fund for Distinguished Young Scholars of Beijing Cancer Hospital
- Open Project Funded by Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education
Zitieren
APA
Weng, K., Chen, J., Tan, F., Song, L., Song, T., Yang, X., Xu, K., Yang, H., & Su, X. (2026). Methylmalonic Acid Induces Oxaliplatin Resistance Through Promoting DNA Damage Repair via the ATM/ATR Pathway in Gastric Cancer. The FASEB Journal. https://doi.org/10.1096/fj.202600528r
Vancouver
Weng K, Chen J, Tan F, Song L, Song T, Yang X, et al. Methylmalonic Acid Induces Oxaliplatin Resistance Through Promoting DNA Damage Repair via the ATM/ATR Pathway in Gastric Cancer. The FASEB Journal. 2026. doi:10.1096/fj.202600528r
BibTeX
@article{Weng2026,
author = {Weng, Kai and Chen, Jiangbo and Tan, Fei and Song, Lin and Song, Tongkun and Yang, Xinying and Xu, Kai and Yang, Hong and Su, Xiangqian},
title = {Methylmalonic Acid Induces Oxaliplatin Resistance Through Promoting DNA Damage Repair via the ATM/ATR Pathway in Gastric Cancer},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202600528r}
}
EUVIMED